Determination and characterization of heteroresisitant vancomycin intermediate staphylococcus aureus from a tertiary care centre

dc.contributor.guideBalaji V and Shalini Anandan
dc.coverage.spatial
dc.creator.researcherYamuna Devi B
dc.date.accessioned2022-02-07T04:39:09Z
dc.date.available2022-02-07T04:39:09Z
dc.date.awarded
dc.date.completed2018
dc.date.registered
dc.description.abstractThe study aimed to characterize the hVISA isolated from the patient identified with MRSA bacteremia. It was also proposed to identify the association between invasive MRSA isolates and the virulence factors PVL and sasX. The potential synergy between oxacillin and vancomycin was also investigated in this study. The study was also intended to understand the epidemiology of MRSA in causing BSI and the genomic comparison of ST772 S. aureus contributes for evolution and expansion. To summarise, increased resistance to clindamycin and trimethoprim-sulfamethoxazole greatly limits the treatment option preferred for treating CA-MRSA infections. It is imperative that high proportion of hVISA is observed among MRSA with the vancomycin MIC of and#8805; 1.5 and#956;g/ml. Increased glycopeptide usage might serve as selection pressure for emergence of hVISA. Clonal association of hVISA, indicates the need of prevention control in practice. The proportion of PVL carrying strains are almost similar between CA and HA-MRSA. The PVL encoding phages and#934;IND772 and and#981;sa119 contributes for the widespread dissemination of PVL in S. aureus strains. In-vitro synergy testing revealed that the combination of beta-lactam plus vancomycin is more bactericidal than vancomyin alone. The presence invasion factors encoding gene sesI and colonisation-invasion virulence factor sasX promotes colonisation mediated invasive MRSA infection and may worsen the clinical outcome. Among MRSA, ST772, ST22 and ST239 were observed as the major clone. The community acquired clone ST772 and the hospital acquired clone are ST239 more multi-drug resistant. The MRSA lineage ST772-SCCmec V is observed as the established multi-drug resistant and highly virulent MRSA clone in India. Acquisition of integrated resistance plasmid and smaller SCCmec variant SCCmec V contributes for the fitness cost to ST772 MRSA strains. Expansion of ST772 strains into hospital is alarming and should be closely monitored for infection prevention control practices. newline
dc.description.note
dc.format.accompanyingmaterialNone
dc.format.dimensions
dc.format.extent406
dc.identifier.urihttp://hdl.handle.net/10603/360304
dc.languageEnglish
dc.publisher.institutionDepartment of Medical
dc.publisher.placeChennai
dc.publisher.universityThe Tamil Nadu Dr. M.G.R. Medical University
dc.relation
dc.rightsuniversity
dc.source.universityUniversity
dc.subject.keywordClinical Medicine
dc.subject.keywordClinical Pre Clinical and Health
dc.subject.keywordMedicine Research and Experimental
dc.titleDetermination and characterization of heteroresisitant vancomycin intermediate staphylococcus aureus from a tertiary care centre
dc.title.alternative
dc.type.degreePh.D.

Files

Original bundle

Now showing 1 - 5 of 12
Loading...
Thumbnail Image
Name:
01_title.pdf
Size:
169.3 KB
Format:
Adobe Portable Document Format
Description:
Attached File
Loading...
Thumbnail Image
Name:
02_certificates.pdf
Size:
1.38 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
03_preliminary pages.pdf
Size:
541.69 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
04_chapter 1.pdf
Size:
368.43 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
05_chapter 2.pdf
Size:
231.24 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: